100 / 2894
79. From RP, Warner DS, Todd MM, et al: Anesthesia
for craniotomy: A double blind comparison of
alfentanil, fentanyl and sufentanil. Anesthesiology
73:896-904, 1990.
80. Keykhah MM, Smith DS, Carlsson C, et al:
Influence of sufentanil on cerebral metabolism and
circulation in the rat. Anesthesiology 63:274-277,
1985.
81. Werner C, Hoffman WE, Baughman VL, et al:
Effects of sufentanil on cerebral blood flow, cerebral
blood flow velocity and metabolism in dogs.Anesth
Analg 72:177-181, 1991.
82. Murkin JM, Farrar JK, TweedWA: Sufentanil anaes-
thesia reduces cerebral blood flow and cerebral
oxygen consumption [abstract]. Can J Anaesth
35:S131, 1988.
83. Mayer N, Weinstabl C, Podreka I, et al: Sufentanil
does not increase cerebral blood flow in healthy
human volunteers. Anesthesiology 73:240-243,
1990.
84. Weinstabl C, Mayer N, Spiss CK: Sufentanil decrea-
ses cerebral blood flow velocity in patients with
elevated intracranial pressure. Eur J Anaesthesiol
9:481-484, 1992.
85. Weinstabl C, Mayer N, Richling B, et al: Effect of
sufentanil on intracranial pressure in neurosurgical
patients. Anaesthesia 46:837-840, 1991.
86. Werner C, Kochs E, Hoffman WE, et al: Sufentanil
does not change cerebral hemodynamics and ICP
in head injured patients [abstract]. J Neurosurg
Anaesthesiol 4:313, 1992.
87. Jamali S, Ravussin P, Archer D, et al: The effects of
bolus administration of opioids on cerebrospinal
fluid pressure in patients with supratentorial lesions.
Anesth Analg 82:600-606, 1996.
88. Lauer KK, Connolly LA, Schmeling WT: Opioid
sedation does not alter intracranial pressure in
head injured patients. Can J Anaesth 44:929-933,
1997.
89. Sperry RJ, Bailey PL, Reichman MV, et al: Fentanyl
and sufentanil increase intracranial pressure in
head trauma patients. Anesthesiology 77:416-420,
1992.
90. Werner C, Kochs E, Bause H, et al: Effects of sufen-
tanil on cerebral hemodynamics and intracranial
pressure in patients with brain injury. Anesthesio-
logy 83:721-726, 1995.
91. Bristow A, Shalev D, Rice B, et al: Low-dose synthe-
tic narcotic infusions for cerebral relaxation during
craniotomies. Anesth Analg 66:413-416, 1987.
92. Shupak RC, Harp JR: Comparison between high-
dose sufentanil-oxygen and high-dose fentanyl-
oxygen for neuroanaesthesia. Br J Anaesth 57:375-
381, 1985.
93. Warner DS, Hindman BJ, Todd MM, et al: Intra-
cranial pressure and hemodynamic effects of remi-
fentanil versus alfentanil in patients undergoing
supratentorial craniotomy. Anesth Analg 83:348-
353, 1996.
94. Ostapkovich N, Baker KZ, Fogerty-Mack P, et al:
Cerebral blood flow and CO
2
reactivity is similar
during remifentanil/N
2
O and fentanyl/N
2
O anes-
thesia. Anesthesiology 89:358-363, 1998.
95. Wagner K,Wiloch F,Kochs E,et al: Dose-dependent
regional cerebral blood flow changes during remi-
fentanil infusion in humans. Anesthesiology 94:
732-739, 2001.
96. Lorenz I, Kolbitsch C, Hormann C, et al: The
influence of nitrous oxide and remifentanil on cere-
bral hemodynamics in conscious human volunteers.
Neuroimage 17:1056-1064, 2002.
97. Kofke WA, Blissitt PA, Rao H, et al: Remifentanil-
induced cerebral blood flow effects in normal
humans: Dose and ApoE genotype. Anesth Analg
105:167-175, 2007.
98. Ostapkovich ND, Baker KZ, Fogarty-Mack P, et al:
Cerebral blood flow and CO
2
reactivity is similar
during remifentanil/N
2
O and fentanyl/N
2
O anes-
thesia. Anesthesiology 89:358-363, 1998.
99. Forster A, Juge O, Louis M, et al: Effects of a specific
benzodiazepine antagonist (RO 15-1788) on cere-
bral blood flow. Anesth Analg 66:309-313, 1987.
100. Veselis RA, Reinsel RA, Beattie BJ, et al: Midazolam
changes cerebral blood flow in discrete brain
regions: an H
2
15
O positron emission tomography
study. Anesthesiology 87:1106-1117, 1997.
101. Forster A, Juge O, Morel D: Effects of midazolam on
cerebral hemodynamics and cerebral vasomotor
responsiveness to carbon dioxide. J Cereb Blood
Flow Metab 3:246-249, 1983.
102. Wolf J, Friberg L, Jensen J, et al: The effect of the
benzodiazepine antagonist flumazenil on regional
cerebral blood flow in human volunteers. Br J
Anaesth 34:628-631, 1990.
103. Knudsen L, Cold GE, Holdgard HO, et al: Effects of
flumazenil on cerebral blood flow and oxygen con-
sumption after midazolam anaesthesia for cranio-
tomy. Br J Anaesth 67:277-280, 1991.
104. Chiolero RL, Ravussin P, Anderes JP, et al: The
effects of midazolam reversal by RO 15-1788 on
cerebral perfusion pressure in patients with severe
head injury. Intensive Care Med 14:196-200, 1988.
105. Misfeldt BB, Jorgensen PB, Spotoft H, et al: The
effects of droperidol and fentanyl on intracranial
pressure and cerebral perfusion pressure in neu-
rosurgical patients. Br J Anaesth 48:963-968,
1976.
106. Michenfelder JD, Theye RA: Effects of fentanyl,
droperidol, and Innovar on canine cerebral meta-
bolism and blood flow. Br J Anaesth 43:630-636,
1971.
107. Strebel S, Kaufmann M, Maitre L, et al: Effects of
ketamine on cerebral blood flow velocity in humans.
Influence of pretreatment with midazolam or
esmolol. Anaesthesia 50:223-228, 1995.
108. Cavazzuti M, Porro CA, Biral GP, et al: Ketamine
effects on local cerebral blood flow and metabolism
in the rat. J Cereb Blood Flow Metab 7:806-811,
1987.
109. Vollenweider FX, Leenders KL, Oye I, et al: Diffe-
rential psychopathology and patterns of cerebral
glucose utilisation produced by (
S
)- and (
R
)-keta-
mine in healthy volunteers using positron emission
tomography (PET). Eur Neuropsychopharmacol
7:25-38, 1997.
110. Vollenweider FX, Leenders KL, Scharfetter C, et al:
Metabolic hyperfrontality and psychopathology in
the ketamine model of psychosis using positron
emission tomography (PET) and [
18
F] fluorodeoxy-
glucose (FDG). Eur Neuropsychopharmacol 7:9-24,
1997.
111. Holcomb HH, Lahti AC, Medoff DR, et al: Sequen-
tial regional cerebral blood flow brain scans using
PET with H
2
15
O demonstrate ketamine actions in
CNS dynamically. Neuropsychopharmacology 25:
165-172, 2001.
112. Schmidt A, Ryding E, Akeson J: Racemic ketamine
does not abolish cerebrovascular autoregulation in
the pig. Acta Anesthesiol Scand 47:569-575, 2003.
113. Mayberg TS, Lam AM, Matta BF, et al: Ketamine
does not increase cerebral blood flow velocity or
intracranial pressure during isoflurane/nitrous
oxide anesthesia in patients undergoing craniotomy.
Anesth Analg 81:84-89, 1995.
114. Strebel S, Kaufmann M, Maître L, et al: Effects of
ketamine on cerebral blood flow velocity in humans.
Influence of pretreatment with midazolam or
esmolol. Anaesthesia 50:223-228, 1995.
115. Sakai K, Cho S, Fukusaki M, et al: The effects of
propofol with and without ketamine on human
cerebral blood flow velocity and CO
2
response.
Anesth Analg 90:377-382, 2000.
116. Albanese J, Arnaud S, Rey M, et al: Ketamine
decreases intracranial pressure and electroencepha-
lographic activity in traumatic brain injury patients
during propofol sedation. Anesthesiology 87:1328-
1334, 1997.
117. Sakabe T, Maekawa T, Ishikawa T, et al: The effects
of lidocaine on canine cerebral metabolism and
circulation related to the electroencephalogram.
Anesthesiology 40:433-441, 1974.
118. Astrup J, Sorensen PM, Sorensen HR: Inhibition of
cerebral oxygen and glucose consumption in the
dog by hypothermia, pentobarbital, and lidocaine.
Anesthesiology 55:263-268, 1981.
119. Lam AM, Donlon E, Eng CC, et al: The effect of
lidocaine on cerebral blood flow and metabolism
during normocapnia and hypocapnia in humans
[abstract]. Anesthesiology 79:A202, 1993.
120. Bedford RF, Persing JA, Pobereskin L, et al: Lido-
caine or thiopental for rapid control of intracra-
nial hypertension? Anesth Analg 59:435-437,
1980.
121. Michenfelder JD, Milde JH: Influence of anesthetics
on metabolic, functional and pathological respon-
ses to regional cerebral ischemia. Stroke 6:405-410,
1975.
122. Michenfelder JD, Sundt TM, Fode N, et al: Isoflu-
rane when compared to enflurane and halothane
decreases the frequency of cerebral ischemia during
carotid endarterectomy.Anesthesiology 67:336-340,
1987.
123. Todd MM, Drummond JC: A comparison of the
cerebrovascular and metabolic effects of halothane
and isoflurane in the cat. Anesthesiology 60:276-
282, 1984.
124. Lutz LJ, Milde JH, Milde LN: The cerebral functio-
nal, metabolic, and hemodynamic effects of des-
flurane in dogs. Anesthesiology 73:125-131, 1990.
125. Scheller MS, Tateishi A, Drummond JC, et al: The
effects of sevoflurane on cerebral blood flow, cere-
bral metabolic rate for oxygen,intracranial pressure,
and the electroencephalogram are similar to those
of isoflurane in the rabbit. Anesthesiology 68:548-
551, 1988.
126. Michenfelder JD, Cucchiara RF: Canine cerebral
oxygen consumption during enflurane anesthesia
and its modification during induced seizures.Anes-
thesiology 40:575-580, 1974.
127. Drummond JC, Todd MM, Scheller MS, et al: A
comparison of the direct cerebral vasodilating
potencies of halothane and isoflurane in the New
Zealand white rabbit. Anesthesiology 65:462-467,
1986.
128. Hansen TD, Warner DS, Todd MM, et al: Distribu-
tion of cerebral blood flow during halothane versus
isoflurane anesthesia in rats.Anesthesiology 69:332-
337, 1988.
129. Lenz C, Rebel A, Klaus V, et al: Local cerebral blood
flow, local cerebral glucose utilization, and flow-
metabolism coupling during sevoflurane versus
isoflurane anesthesia in rats. Anesthesiology 89:
1480-1488, 1998.
130. Heath KJ, Gupta S, Matta BF: The effects of sevo-
flurane on cerebral hemodynamics during propofol
anesthesia. Anesth Analg 85:1284-1287, 1997.
131. Wollman H,Alexander SC, Cohen PJ, et al: Cerebral
circulation of man during halothane anesthesia.
Anesthesiology 25:180-184, 1964.
100
Fisiología y anestesia
I